Tinambacan, Baby Girl .

HRN: 22-28-53  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/03/2022
AMPICILLIN 250MG (VIAL)
12/03/2022
12/10/2022
IV
60mg
Q12hours
PSNB Sec Non-institutional Delivery; RDS Sec Prematurity
Waiting Final Action 

Indication:  Empiric    Type of Infection:  PneumoniaBloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: